Clovis Oncology Inc. buy Traumtanz
Start price
29.01.21
/
70%
€6.91
Target price
€8.00
Performance (%)
16.27%
End price
06.02.21
€8.03
Summary
This prediction ended on 06.02.21 with a price of €8.03. The prediction had a final performance of 16.27%. Traumtanz has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Clovis Oncology Inc. | - | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to Traumtanz what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Clovis Oncology Inc. diskutieren
In the thread Trading Clovis Oncology Inc.
Buy beendet